SCHEMBL22526731

SCHEMBL22526731

CC(C)(C)OC(=O)N[C@@H](CCC(N)=O)COc1cccc(CCCC(=O)O)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 1/20 0.40
▸ PPARA Q07869 2/20 0.40
▸ PPARG P37231 1/20 0.40
▸ CSF3R Q99062 1/20 0.39
▸ PTGIR P43119 1/20 0.38
▸ FFAR1 O14842 1/20 0.38
▸ HDAC3 O15379 1/20 0.38
▸ HDAC4 P56524 1/20 0.38
▸ HDAC1 Q13547 1/20 0.38
▸ HDAC7 Q8WUI4 1/20 0.38
▸ HDAC2 Q92769 1/20 0.38
▸ HDAC10 Q969S8 1/20 0.38
▸ HDAC11 Q96DB2 1/20 0.38
▸ HDAC8 Q9BY41 1/20 0.38
▸ HDAC6 Q9UBN7 1/20 0.38
▸ HDAC9 Q9UKV0 1/20 0.38
▸ HDAC5 Q9UQL6 1/20 0.38
▸ CYSLTR2 Q9NS75 1/20 0.38
▸ CYSLTR1 Q9Y271 1/20 0.38
▸ CTSK P43235 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30169219 1.00 ATM (0.40) ATMPPARAPPARGCSF3RPTGIR
SCHEMBL30169110 0.97 CYSLTR2 (0.41) ATMPPARAPPARGCSF3RPTGIR
SCHEMBL25383035 0.96 PPARA (0.43) ATMPPARAPPARGCSF3RPTGIR
SCHEMBL22525550 0.96 PPARA (0.43) ATMPPARAPPARGCSF3RPTGIR
SCHEMBL30169343 0.94 ATM (0.43) ATMCSF3RFFAR1HDAC3HDAC4
SCHEMBL22526872 0.93 HDAC1 (0.41) ATMPPARAPPARGHDAC3HDAC4
SCHEMBL26237677 0.92 REN (0.40) ATMPPARAPPARGHDAC3HDAC4
SCHEMBL22527004 0.89 ATM (0.42) ATMPPARAHDAC3HDAC4HDAC1
SCHEMBL30169063 0.89 ATM (0.42) ATMPPARAHDAC3HDAC4HDAC1
SCHEMBL25383204 0.89 HDAC1 (0.40) ATMPPARAPPARGHDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11746120-B2 Stat degraders and uses thereof KYMERA THERAPEUTICS, INC. (US) 2023-09-05 — — US disclosed
WO-2020206424-A1 STAT DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2020-10-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11746120-B2 Stat degraders and uses thereof STAT4, STAT1, STAT3 ATM 837/4885PPARA 1856/4885PPARG 1830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback